CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study 会议论文
作者:  Chang, Lung-Ji;  Dong, Lujia;  Liu, Yu-Chen;  Tsao, Shih-Ting;  Li, Ya-Chen
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/06
Increased and sustained HBsAg loss in HBeAg positive CHB patients switched from NUC to Peg-IFN alfa-2a: A randomised open label trial (NEW SWITCH study) 会议论文
作者:  Hu, Peng;  Dou, Xiaoguang;  Jiang, Jian-ning;  Jia, Shang;  Zhang, Wen Hong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/06
Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China 会议论文
作者:  Dong, Lujia;  Chang, Lung-Ji;  Gao, Zhiyong;  Lu, Dao-Pei;  Zhang, Jian-Ping
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/19
Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia 会议论文
作者:  Chang, Lung-Ji;  Dong, Lujia;  Guo, Hao-Hsiang;  Zhang, Jian-Ping;  Gao, Zhi-Yung
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/19
High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study 会议论文
作者:  Zheng, Jin-Ping;  Wen, Fu Qiang;  Bai, Chun-Xue;  Wan, Huan-Ying;  Kang, Jian
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace